Kidney Cancer News

Five-year results see Exelixis’ RCC therapy extending overall survival

Studied in combination with Opdivo, Cabometyx saw RCC patients surviving 11 months longer than Sunitinib patients ...

Kidney Cancer Vaccine Shows Promise in Early Trial The vaccine generated robust immune response in nine patients ...

Lessons learned Hello everyone, my name is Scott. I’m in my late 50s and have been living with Stage 4 ...

Renal Mass Biopsy is Associated With Fewer Radical Nephrectomies for Benign or Indolent Disease, Particularly for ...

This is from the cancernetwork.com At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with ...

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma The ...

A new positron emission computed tomography (PET) agent achieves “exceptional” imaging quality of lesions in ...

Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis ...

Recently published in the New England Journal of Medicine, findings from the pivotal phase 3 trial, KEYNOTE-564, ...

NEW Kidney Cancer UK Patient Survey 2023 Report FINDS KIDNEY CANCER PATIENTS ARE BEING MISDIAGNOSED, CONFUSED ...

Kidney Cancer UK is delighted to present our first Webinar for 2024 on Tuesday January 16th at 6pm, ‘Counselling – ...

Merck partners with HiberCell for Phase Ib renal carcinoma trial The Phase Ib trial will evaluate the ...